Interpace Biosciences Inc PEG
¿Qué es el PEG de Interpace Biosciences Inc?
El PEG de Interpace Biosciences Inc es N/A
¿Cuál es la definición de PEG?
La relación precio/ganancias al crecimiento (PEG) es la relación P / E de una acción dividida por una tasa de crecimiento prevista de sus ganancias durante un período de 5 años.
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG de compañías en Sector Health Care en NASDAQ en comparadas con Interpace Biosciences Inc
¿Qué hace Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Empresas con peg similar a Interpace Biosciences Inc
- Otonomy Inc tiene PEG de N/A
- Akcea Therapeutics Inc tiene PEG de N/A
- Bombardier tiene PEG de N/A
- Dawson Geophysical tiene PEG de N/A
- Entercom Communications Corp tiene PEG de N/A
- Town Sports International tiene PEG de N/A
- Interpace Biosciences Inc tiene PEG de N/A
- Aqua Metals Inc tiene PEG de N/A
- Babcock & Wilcox Enterprises Inc tiene PEG de N/A
- Ferroglobe Plc tiene PEG de N/A
- Icon tiene PEG de N/A
- Sorrento Therapeutics Inc tiene PEG de N/A
- United States Steel tiene PEG de N/A